Linoleic acid was isolated from both the methanol extracts of proso and Japanese millet as a histone deacetylase inhibitor. It showed uncompetitive inhibitory activity toward histone deacetylase (IC 50 ¼ 0:51 mM) and potent cytotoxicity toward human leukemia K562 (IC 50 ¼ 68 M) and prostate cancer LNCaP cells (IC 50 ¼ 193 M). Millet containing linoleic acid might have anti-tumor activity.
Histones are small basic proteins formed by complexing with DNA to give the nucleosome core and "-amino groups of lysine in them are modified by histone acetyl transferases (HATs) and histone deacetylases (HDACs). They can be present in one of the two antagonist forms, acetylated and deacetylated, regulated by HATs and HDACs, and are involved in transcription regulation. HDAC inhibitors are emerging as potential therapeutic agents for cancer, because HDACs play a fundamental role in regulating gene expression and the chromatin assembly that induces growth arrest, differentiation and apoptosis of tumor cells. 1, 2) A saturated fatty acid of the short chain (C4), sodium butyrate, is known as the first HDAC inhibitor and is a differentiating agent for many tumor cells. 3, 4) In addition, butyric acid derived from the fermentation products of dietary fiber by anaerobic microflora within the lumen of the large intestine inhibits HDACs, and induces caspase-3 protease activity and apoptosis. 5, 6) Thus, HDAC inhibitors in a food ingredient may be a useful compound for preventing cancer. 7) Millet is an important food source in Africa and Asia. It has been reported that feeding a protein concentrate of proso millet (Panicum miliaceum L.) elevated the plasma level of the high-density lipoprotein (HDL) cholesterol concentration in rats and mice. 8) In addition, this protein has a preventive effect on liver injury. 9) Choi et al. have also demonstrated that feeding a protein concentrate of Korean foxtail millet resulted in a significant rise in the plasma levels of HDL cholesterol and adiponectin, and a large reduction in the insulin concentration of genetic type 2 diabetic model mice, suggesting improved insulin resistance. 10) These results suggest the potent beneficial effect of these types of millet on human health, although there has been no report on the anti-tumor effect of millet until now.
In the course of our screening program to find inhibitors of HDAC by using six hundred kinds of MeOH extract of plants (a fifth of them are food ingredients) and the HDAC colorimetric assay/drug discovery kit (AK-501, BIOMOL), each MeOH extract of commercial proso millet (Mochikibi) and Japanese millet (Hie), which are traditional types of millet in the northern area of Japan, showed about 80% HDAC inhibitory activity at the final concentration of 400 mg/ ml, but not foxtail millet (Mochiawa). We describe the isolation, identification and biological activity of the inhibitors from these millet samples in this paper.
Commercial proso millet and Japanese millet (174.3 g and 163.6 g, respectively) was separately ground in a mixer and extracted with MeOH. Each MeOH extract (3.69 g and 2.01 g) was diluted with an excess of water and extracted twice with EtOAc. After evaporating EtOAc, the organic layer (2.71 g and 1.28 g) was subjected to silica gel TLC (0.75 mm, 20 Â 20 cm, Silicagel 70 PF 254 (Wako Pure Chemical Industries)) developed with a CHCl 3 :MeOH solvent (100:1). The active fraction (Rf ¼ 0:26{0:38) was scraped off and eluted from the silica gel with MeOH. Finally, the active compound in each (1.34 g and 0.61 g) was dissolved in MeOH, and the inhibitor purified by HPLC (CAPCELL PAK C 18 (10 mm' Â 250 mm) Shiseido, 3.0 ml/min) y To whom correspondence should be addressed. Fax: +81-19-621-6124; E-mail: kimurak@iwate-u.ac.jp Abbreviations: HAT, histone acetyl transferase; HDAC, histone deacetylase; HDL, high-density lipoprotein; LA, linoleic acid; SAR, structureactivity relationship; PUFA, polyunsaturated fatty acid; CYP17, 17-hydroxylase/C 17;20 -lyase Both active compounds were similar, judging from this physico-chemical properties and biological activity. The molecular formula was C 18 H 32 O 2 by HR-ESI-MS ((nega.) m=z: 279.24987 ðM À HÞ À ) (JMS-T100LC), and the UV spectrum showed end absorption. The 1 H-NMR and 13 C-NMR spectra indicated the inhibitors to have a long alkyl chain with two double bonds and a carboxylic acid. The positions of two double bonds were determined to be at C9 and C12 in the alkyl chain by a fragmentation analysis (m=z ¼ 221, 181 and 127) of the FAB/MS/MS spectra (Jeol JMS-HX/HX110 A). These data indicated that the active compound was 9, 12-octadecadienoic acid. Finally, linoleic acid (LA), i.e., (cis-9, cis-12)-octadecadienoic acid, was identified by a comparison of the retention time by HPLC and the activity of the standard sample (Wako Pure Chemical Industries).
LA (IC 50 ¼ 0:51 mM), an unsaturated fatty acid of the long-chain (C18) type, had almost the same HDAC inhibitory activity as butyric acid (IC 50 ¼ 0:45 mM, it was 2.6-fold stronger than sodium butyrate (IC 50 ¼ 1:33 mM)) ( Table 1) . It inhibited HDAC uncompetitively, judging from the Lineweaver-Burk plot shown in Fig. 1 . As butyric acid and LA are very different fatty acids in their structure, we investigated the structure-activity relationship (SAR) of the saturated and unsaturated fatty acids in respect of the HDAC inhibitory activity. The HDAC inhibitory activities of various fatty acids (Wako Pure Chemical Industries) are shown in Table 1 . Arachidonic acid (IC 50 ¼ 0:27 mM), which had 1.9-fold stronger inhibitory activity than LA, had the strongest HDAC inhibitory activity of the examined fatty acids. The activity strength of fatty acids having aliphatic chains of 18 carbons was in the order of -linolenic acid >-linolenic acid >LA >(cis-9, trans-11)-octadecadienoic acid (the conjugated isomer of LA) >oleic acid, whereas the saturated fatty acids, except for butyric acid, had no inhibitory activity even at 1 mM ( Table 1 ). The length of the aliphatic chain and the presence of the double bond were critical for the HDAC inhibitory activity of fatty acids. The double bond might have been involved in the increased flexibility of the long aliphatic chain and/or the strong interaction in the active-site pocket. Trichostatin A, which is a potent HDAC inhibitor (IC 50 ¼ 7:8 nM in our assay), isolated from Streptomyces hygroscopicus showed 30-fold stronger HDAC inhibitory activity than suberoylanilide hydroxamic acid without the double bond. [11] [12] [13] A carbonyl group in the fatty acids might also have reacted with the active site, because sodium butyrate and valproic acid both have the carbonyl group in each molecule. 7, 14) In contrast, ricinoic acid with a hydroxyl group at the C12 position had less inhibitory activity than oleic acid ( Table 1 ). The hydrophilic moiety might not have interacted with the hydrophobic portion of the active site.
We investigated the cytotoxicity of LA against tumor cells by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide) assay (Chemicon International). 15, 16) LA showed cytotoxicity against cells of human chronic myelogenous leukemia K562 (ATCC CCL-243, IC 50 ¼ 68 mM comparable to IC 50 ¼ 13:4 mM of arachidonic acid) and human prostate carcinoma LNCaP (ATCC CRL-1740, IC 50 of 193 mM) (Fig. 2) . The cytotoxicity of LA was 2-to 4-fold stronger than the HDAC inhibitory concentration. The cytotoxicity against tumor cells by such unsaturated fatty acids as LA might have resulted from the HDAC inhibitory activity, in addition to other inhibitory activity such as lipid peroxidation, DNA polymerase 17, 18) and CYP17 (17-hydroxylase/C 17;20 -lyase) (IC 50 ¼ 0:13 mM (17-hydroxylase reaction)/IC 50 ¼ 0:17 mM (C 17;20 -lyase reaction)).
Proso and Japanese millet containing LA, which was an HDAC inhibitor, could be useful in preventing cancer like oleic acid of olive oil and polyunsaturated fatty acids (PUFAs) like -linoleic acid that had HDAC inhibitory activity in this study (Table 1) . 19, 20) Proso and Japanese millet also included such other fatty acids as, oleic acid and -linoleic acid, the amount of LA in them being proportional to the inhibitory activity toward HDAC and cancer cell growth (data not shown). Although the anti-tumor activity of PUFAs including LA in vivo is contradictory, our results show the fascinating explanation that the anti-tumor effects of PUFAs might depend on this HDAC inhibitory activity and/or CYP17 inhibitory activity, 21) since the HDAC inhibitory activity of various MeOH extracts of millet was correlated with the CYP17 inhibitory activity involved in the growth inhibition of prostate cancer for the lack of androgen (Kimura, K., et al., Biosci. Biotechnol. Biochem., in press). We plan to examine the anti-tumor activity of millet having a high content of LA against tumor-bearing mice. C in a humidified, 5% CO 2 atmosphere for 4 days in an RPMI 1640 medium supplemented with 10% fetal bovine serum, 50 units/ml of penicillin and 50 mg/ml of streptomycin, and the cytotoxicity was determined by an MTT assay. The percentage of viable cells was calculated as the ratio of the A 570 values of treated and control cells (treated with the 0.05% MeOH vehicle). Each value is the average of four independent experiments. , K562 cells; , LNCaP cells.
